


























Investment Summary & Thesis 
I am initiating a buy recommendation for 3M with a target price of $245.16. This target price 
represents a 40% upside from the $175.06 closing price on February 26th, 2021.  
Key Drivers: 
• Increased spending on research and development (R&D) and capital investment 
o Part of 3M’s strategy to differentiate themselves from the competition is an 
emphasis on innovation. While 3M has a host of successful legacy products, they 
have a well-tracked goal for each segment to recognize 30% of their revenues 
from products introduced in the last four years. This culture of innovation has 
been very successful for 3M and the budget for R&D has been steadily increasing 
over the last ten years. However, a recent commitment to 6% of sales to R&D 
marks a significant increase.  
• Strong leadership 
o Several new Corporate Officers at 3M have ushered in strategies that demonstrate 
a strong understanding of advantages over competitors. 3M CEO and Chairman of 
the Board Michael Roman has put forth four target priorities for driving growth: 
Portfolio, Transformation, Innovation, and People & Culture. This demonstrates a 
strong understanding of the difference between 3M’s business level strategy and 
corporate level strategy. While 3M is a manufacturer of many goods, at a 
corporate level the company is more a portfolio manager that must identify, 
evaluate, and capture synergies between manufacturing operations. 
  
 3M’s Market Profile 
 
  
Ticker                   NYSE:MMM 
Share Price                    $175.06 
Market Cap                   103.52B 
Beta                                     0.95 
Debt / Equity                       1.46 
P / E                                   18.93 
P / Book                               7.87 
ROE                               47.10% 





3M, formerly Minnesota Mining and Manufacturing Company, is a multinational manufacturing 
conglomerate founded in 1902 in Two Harbors, MN. The company offers over 60,000 products 
grouped into four main business segments: Safety & Industrial, Transportation & Electronics, 
Healthcare, and Consumer. 3M has 96,000 employees and operates in more than 70 countries 
across the world.  
3M’s business model relies on expertise in product development, manufacturing, and marketing. 
The company acquires, either through internal development or purchase, roughly 3,000 new 
patents each year. This culture of innovation is a major differentiator for 3M and helps drive 
premium margins for the company. It also gives 3M an edge in attracting bright and inquisitive 
minds thus perpetuating the cycle. While traditional convention is for businesses to be rewarded 
for specializing their activities, 3M captures value from their wide variance of operations. An 
obvious benefit of 3M’s heterogeneity is diversification in terms of industry-specific risk.  
Headquartered in Maplewood, MN, 3M sees 40.9% of sales from within the United States, 
30.5% from Asia Pacific, 19.4% from Europe, Middle East, & Africa, and 9.2% from Latin 
America & Canada. By business segment, Safety and Industrial is the largest with 34.4% of net 






Management and Corporate Governance 
Corporate Officers 
Michael Roman has been the CEO of 3M since July 2018. 
Under his guidance 3M has undergone a successful 
reorganization of business groups to better serve customers’ 
needs. Roman has worked at 3M for 30 years and prior 
roles include leading 3M’s largest business group, chief 
strategist, and COO. With this experience he has a well-
developed knowledge of the company and its strengths. 
Roman has advanced four priorities to drive growth, 
Portfolio, Transformation, Innovation, and People & 
Culture. These play into the 3M value model of delivering 
to all stakeholders, including increasing dividends for 61 
consecutive years. 
Board of Governors 
3M currently has 12 members serving on the Board of Governors. All of these members with the 
exception of Michael Roman (CEO of 3M) and James Fitterling (CEO DOW Inc.) serve on at 
least one committee, but no more than two committees. The Audit, Compensation, Nominating 
& Governance, and Science, Technology & Sustainability committees serve to divide 
responsibilities and power of board members. Three main goals of the Board are (1) Director 
Orientation and Continuing Education: this serves to ensure that new board members know the 
company and their role, as well as keeping existing directors up to date on skills and knowledge 
necessary for their job. (2) Risk Oversight: The Board as a whole as well as individual 
committees oversee the risk profile and processes for managing the risk of the company. (3) 
Long-Term Strategies: The Board approves strategic plans and capital allocation on a yearly 







3M can be placed in the Specialty Industrial Manufacturing industry; however, for analysis of 
the company’s future outlook it is more useful to examine the industries that define 3M’s 
business segments. 
The industrial industry is currently poised growth. Low interest and mortgage rates will drive 
new project starts that will fuel industrial industry growth in the short-term outlook. Through 
2020, many supply chains were disrupted due to lockdown caused by the COVID-19 pandemic. 
These interruptions made it impossible to get some materials and raised the prices of others 
which took a toll on the industrial industry. Restoration of these supply chains and material 
prices returning to more normal values will compound the effects of low interest rates 
culminating in a strong rebound for the industry.  
Freight tonnage is forecasted to grow up to 25% by the year 2030. This growth expectation for 
the next ten years should see competition and growth throughout the transportation industry. 
There is potential for disruption of the industry with the possible adoption of electric vehicles in 
place of traditional internal combustion engines. While this has the potential to shake up the 
large players in the transportation industry, 3M’s sales should be relatively unaffected because 
the nature of their products is not dependent on the type of vehicle.  
The healthcare industry has undergone significant changes in the last year again due to COVID-
19. It is predicted that the industry will see large numbers of delayed visits and optional 
procedures returning as vaccine distribution alleviates COVID-19 restrictions. Competition 
within the industry is expected to be strong and a large trend is investment into digital 
technology, specifically electronic health records systems. These investments are projected to 
increase efficiency which could see more visits and increase 3M’s sales in this industry. 
The consumer retail industry, due to its broad nature, has seen vastly differing reactions to 
COVID-19 in the last year. Generally, vaccine distribution and lowering restrictions see more 
people returning to work. This coupled with stimulus checks has seen increases in consumer 
confidence and spending. 3M participates mostly in the nondurable portion of the industry which 
has fared much better in the last year. These staples of home and office supplies are fairly stable 
and do not expect high growth, rather steady performance with moderate gains.  
Looking back into the specialty industrial manufacturing industry 3M is among the top four 
leaders, all over $100 billion market cap. 3M has always been an industry leader in terms of 
innovation which could prove extremely beneficial as an uncertain world emerges from the 
pandemic. If global routines return to normal 3M knows they can rely on certain legacy products 
to generate profits, but a populous more cognizant of mitigating disease transmission could 
present a massive opportunity for 3M. Already working in consumer and healthcare industries 
and spending more than ever on R&D, 3M has the potential for a leap forward in their industry 








3M has a strong, but fairly slow trend in increasing total revenues for the last ten years. 
Increasing from  $26,662 million in 2010 to $32,184 in 2020 represents a compound annual 
growth rate of 1.90%. EBITDA has grown more impressively in the same timeframe holding a 
compound annual growth rate of 2.47%. Net margin increased from 2010 to 2015 and held 
steady for the last five years around 28%. 
Profitability 
 
3M has had a very impressive ROE over the last decade with a low of only 24.6%. Since 2015 
the ROE has bounced around a little but never fallen below 40%. Diluted EPS for 3M have 
shown impressive growth as well. In 2010 EPS was $5.63 but has risen with fairly high 
consistency for the last ten years ending 2020 with $9.25 which represents a compound annual 













Ratios Over Time 
Over the last ten 
years 3M’s P/E 




During this same 
timeframe, 3M has seen an upward trend in P/E while Honeywell has for the most part remained 
flat. While 2020 saw a slight decrease in P/E for 3M, I believe coming out of the COVID-19 
driven economic downturn, 3M can continue its upward trend making it an ideal investment at 
this time.  
 
Comparison to Competitors 
 Market 
Cap 
P / E P / FCF ROE Operating 
Margin 
Johnson & Johnson 424.22B 29.34 58.27 24.50% 19.80% 
Honeywell International 
Inc. 
140.71B 30.14 51.92 26.80% 18.40% 
General Electric Company 106.38B 20.97 - 14.70% 15.10% 
3M Company 103.00B 18.93 31.95 47.10% 22.20% 
Illinois Tool Works Inc. 63.34B 30.53 53.14 80.20% 22.90% 
Emerson Electric Co. 50.90B 24.88 29.70 25.50% 15.70% 
DuPont de Nemours Inc. 37.32B - 12.87 -7.70% -11.30% 
Avery Dennison 
Corporation 
14.38B 26.48 48.84 42.30% 9.00% 
Arconic Corporation 2.33 16.97 - 0.80% 4.70% 
      
Average  24.78 40.96 28.24% 12.94% 
Comparable companies were considered using two factors. First a screener narrowed down on 
companies within the specialized industrial manufacturing industry. Second competitors were 
deemed as useful considerations if they too manufactured a wide and diverse set of products, not 
necessarily in the same industries as 3M, but across several industries to achieve a like 
diversification. In comparison to competitors, 3M is in the middle of the pack as far as market 
capitalization. 3M trades cheaply in comparison to competitors in terms of both price to equity 
and price to free cash flow placing well below the averages. 3M also has impressive profitability 
metrics compared to the competition ranking 2nd in both ROE and operating margin and far 
above the average. Comparing to competitors strengthens the case in favor of investing in 3M. 
The only instances of rivals comparing to 3M’s above average ROE and operating margin are all 





For the valuations in this report the 3M historical data used was obtained from S&P 500 Capital 
IQ. A compound annual growth rate for dividends was calculated to be 10.73% over the last ten 
years (roughly the same position in time as the current business cycle) and 8.27% over the entire 
history of 3M dividends. Cost of equity capital was calculated to be 5.62% using the 10-year T-
note rate of 1.35%, a market risk premium of 4.50% and beta of 0.95.  
Dividend Discount Model (DDM) 
Scenario #1: For the first DDM calculation a three-stage model was used. Stage 1 
dividend growth was 8.00% which was rounded down from the historical compound annual 
growth rate and assumed for 10 years. Stage 2 was 4.00% for another 10 years and a constant 
1.00% growth rate was assumed for stage 3.  These assumptions resulted in a calculated fair 
value of $249.28  
Scenario #2: The second DDM simply assumed a 3.00% constant growth rate which is 
highly conservative compared to historical data and recent trends. This model resulted in a 
calculated fair value of $241.05 
Free Cash Flow to Equity Model (FCFEM) 
In an effort to calculate an accurate fair price the FCFEM used an average of the last three years’ 
unlevered free cash flows because 2020 had an exceptionally high FCF. This resulted in a FCF 
compound annual growth rate of 3.83%. This resulted in a calculated fair price of $529.84. This 
price seems unattainable and was ultimately not used for the final target price of this report; 
however, it points to the fact that 3M’s cash flows have characteristics associated with high 
value. I also believe that this valuation is inflated due to a shift in capital structure at 3M in the 
last ten years which has resulted in debt overtaking equity for the main component. 
Conclusion 
Through the use of use of two different valuation models and conservative growth numbers 
based on values calculated form historical data all indications point to 3M being currently 
undervalued. The final price target of this report, $245.16 is a simple average of the two DDM 
valuations and does not include the even higher FCFEM valuation. This price target represents a 









• As a multinational company, 3M faces several international risks. Foremost among these 
is foreign exchange risk. Roughly 60% of 3M revenue comes from outside the United 
States which could be adversely affected if the US dollar strengthens significantly against 
currencies that are important to 3M. Additionally, geopolitical and regulatory risks are 
present to an investment in 3M. Tariffs and/or trade wars as well as regulatory changes in 
any of the 70+ countries that the company does business in could damage performance. 
Materials Price Fluctuation & Availability 
• 3M manufacturing operations greatly rely on raw materials and energy. The supply 
chains for these resources can be disrupted or even terminated by natural disasters or 
other unexpected events. Sustained interruptions could massively damage 3M’s 
performance. 3M does have systems in place to prevent and mitigate damage in the 
occurrence of disruptions. However, stringent inventory management combined with 
development and qualification of other supply sources cannot wholly remove this risk. 
Credit Downgrade 
• Currently 3M has a AA- credit rating and is facing a credit rating downgrade if they take 
on too much more debt. This would hurt the company’s cost of capital and could limit 
acquisitions or other actions in the future. However, 3M is currently far more levered 
than usual and as such are acutely aware of their position. Taking advantage of current 
low interest rates seems like a beneficial move and as of now 3M has not overextended 
themselves in this pursuit. 
Portfolio Management Actions 
• Any changes to the 3M portfolio, be it acquisition, divestures, or alliances, have the 
potential to boost or damage the company’s performance. It is essential that in these 
portfolio altering actions 3M integrates and captures synergies quickly to capture profit. 
While 3M has a strong track record, changes to the company’s portfolio will always be a 
risk 3M faces. 
Environmental Lawsuits 
• 3M is currently involved in a lawsuit centered around the use of perfluoroalkyls and 
polyfluoroalkyls in their products. In 2000 the company voluntarily started phasing out 
and entirely stopped using these substances in 2002, but the nature of the strong bonds of 
these compounds means that they do not break down easily. While the lawsuit involving 
pollution from these chemicals has already been settled with the state of Minnesota, 
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